| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.5 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |